Home Cart Sign in  
Chemical Structure| 220127-57-1 Chemical Structure| 220127-57-1
Chemical Structure| 220127-57-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Imatinib Mesylate (STI571 Mesylate) is a tyrosine kinase inhibitor that targets c-Kit, Bcr-Abl, and PDGFR, with an IC50 of 100 nM.

Synonyms: STI571 Mesylate; CGP-57148B Mesylate; STI-571

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations

Jiang, Qi ; Ghosh, Rittik K ; Valdivia-Berroeta, Gabriel A ; Walder, Brennan J ; Luo, Laibin ;

Abstract: We focused on the critical role of crystallization of active pharmaceutical ingredients (APIs) in drug development, with particular emphasis on stability, solubility, and the feasibility of drug formulation and manufacturing. We explored polymorphism in APIs and the formation of multicomponent crystals, including salt and cocrystal screening, underscoring the significance of regulatory and intellectual property considerations in recognizing salts and cocrystals of solid forms. Our study led to the design of seven new multicomponent crystalline forms of imatinib, an oncology API. Using X-ray crystallography and solid-state NMR, we elucidated hydrogen bonding interactions and proton transfer, unveiling multicomponent interactions in the crystalline solid forms along the salt−cocrystal continuum. Most of the new solid forms demonstrated improved aqueous solubility compared to that of the free base form. This research provides valuable insights into the structural details of solid forms of pharmaceutical compounds and emphasizes the importance of understanding solid-state interactions for the rational design of crystalline APIs, thereby enhancing the drug development process.

Purchased from AmBeed: ;

Alternative Products

Product Details of Imatinib Mesylate

CAS No. :220127-57-1
Formula : C30H35N7O4S
M.W : 589.71
SMILES Code : O=C(NC1=CC=C(C)C(NC2=NC=CC(C3=CC=CN=C3)=N2)=C1)C4=CC=C(CN5CCN(C)CC5)C=C4.CS(=O)(O)=O
Synonyms :
STI571 Mesylate; CGP-57148B Mesylate; STI-571
MDL No. :MFCD04307699
InChI Key :YLMAHDNUQAMNNX-UHFFFAOYSA-N
Pubchem ID :123596

Safety of Imatinib Mesylate

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H332-H335
Precautionary Statements:P261-P280-P305+P351+P338
 

Historical Records

Categories